CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
transcranial direct current stimulation (tDCS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05194267
NCT05194267N/ACompleted
CompareCT.gov

Intensive Transcranial Direct Current Stimulation in the Treatment of Major Depression: Feasibility Study

Centre hospitalier de l'Université de Montréal (CHUM)·interventional·Posted Jan 18, 2022·Updated Jul 28, 2025

In Brief

A clinical study evaluating transcranial direct current stimulation (tDCS) for Major Depressive Disorder. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disorder (MDD). Participants will be age 18-65 with a diagnosis of unipolar MDD. Participants will receive an intensive treatment of tDCS over a 10-day treatment period and complete follow-up assessments at the end of treatment, 1, and 4 weeks post-treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 18, 2022
Enrollment StartFeb 2, 2022
Primary CompletionAug 16, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.5 years ago

Interventions

transcranial direct current stimulation (tDCS)device

tDCS alters brain excitability using a weak electric field induced through two electrodes and could potentially improve symptoms of depression